These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8733902)

  • 21. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
    Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
    Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 23. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.
    Sedlmayr P; Plecko B; Paschke E; Zenz W; Ramschak H; Toplak H; Wascher TC; Wilders-Truschnig M; Stöckler S
    J Inherit Metab Dis; 1995; 18(1):101-2. PubMed ID: 7623436
    [No Abstract]   [Full Text] [Related]  

  • 25. Dietary management of X-linked adrenoleukodystrophy.
    Moser HW; Borel J
    Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
    Moser HW; Moser AB; Hollandsworth K; Brereton NH; Raymond GV
    J Mol Neurosci; 2007 Sep; 33(1):105-13. PubMed ID: 17901554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.
    Pour RB; Stöckler-Ipsiroglu S; Hunneman DH; Gahr M; Korenke GC; Pabst W; Hanefeld F; Peters A
    J Inherit Metab Dis; 2000 Mar; 23(2):113-9. PubMed ID: 10801052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
    Ferri R; Chance PF
    Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy of X-linked adrenoleukodystrophy.
    Moser HW
    NeuroRx; 2006 Apr; 3(2):246-53. PubMed ID: 16554262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrine disease in adrenoleukodystrophy].
    Girard S; Bruckert E; Turpin G
    Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
    Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
    Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
    Moser HW
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):740-5. PubMed ID: 7666063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycerol trioleate/glycerol trierucate therapy in X-linked adrenoleukodystrophy: saturated and unsaturated fatty acids in blood cells. Implications for the follow-up.
    Ruiz M; Pampols T; Girós M
    J Inherit Metab Dis; 1996; 19(2):188-92. PubMed ID: 8739962
    [No Abstract]   [Full Text] [Related]  

  • 34. [Primary adrenal insufficiency as the form of onset of adrenoleukodystrophy in a 4-year-old boy].
    Tornero Patricio S; de la Vega JA; Nehme Alvarez D; Gentil González FJ; Lluch Fernández MD; González Hachero J
    Endocrinol Nutr; 2009 Jan; 56(1):40-2. PubMed ID: 19627707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil.
    Moser HW; Powers JM; Smith KD
    Brain Pathol; 1995 Jul; 5(3):259-66. PubMed ID: 8520725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleeding in a patient taking Lorenzo's oil: evidence for a vascular defect.
    Chai BC; Etches WS; Stewart MW; Siminoski K
    Postgrad Med J; 1996 Feb; 72(844):113-4. PubMed ID: 8871463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of adolescent adrenoleukodystrophy with clinical improvement after allogeneic bone marrow transplantation (allo-BMT)].
    Tsujii T; Kinoshita M; Tomimoto H; Hitomi T; Okazaki T; Uchiyama T; Shibasaki H
    Rinsho Shinkeigaku; 2004 Oct; 44(10):667-72. PubMed ID: 15568481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelets in treated adrenoleukodystrophy: a brief report.
    Revell P; Green A; Green S
    J Inherit Metab Dis; 1995; 18(5):635-7. PubMed ID: 8598646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lorenzo's oil may help to prevent ALD symptoms.
    Senior K
    Lancet Neurol; 2002 Dec; 1(8):468. PubMed ID: 12849323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.